فارسی
(Pre) Clinical Cancer Research Group
(Pre) Clinical Cancer Research Group
Karazmaei Saratan Iranian Pishro Co.
No: 516882


«Leadership»
Dr. A. M. Alizadeh

Dr. Ali Mohammad Alizadeh

CEO

+98-912-5790941

aalizadeh@sina.tums.ac.ir , alizadehtums92@gmail.com


Ali Mohammad Alizadeh founded "Karazmaei Saratan Iranian Pishro Co." in 2017. Prior to co-founding the firm, Ali was Associate Professor & Principal Investigator at Cancer Institute of Iran affilaited to Tehran University of Medical Sciences (TUMS) after he had received his Ph.D in Medical Physiology.

Besides his efforts for Design, set up and conduct of various student projects in different clinical trial sites and collaboration with different Iranian and foreign medical universities, Ali has 10 years management experience in Preclinical and Clinical Trial from Academic to Contract Research Organizations (CROs) focused in Cancer Biology, Cardiac Regeneration, Drug Discovery and Cell Therapy based on Good Clinical Practice (GMP).

In addition, he is currently trying to organize an expert team for both initiates and expands Investigational New Drug (IND) and New Drug Application (NDA) in Iran. As a Leader, his valuable goal is making opportunities for development of accelerated parallel strategies for cooperation between Industry and academic research.



© Copyright 2014-2017 by (Pre) Clinical Cancer Research Group. All rights reserved.